Your browser doesn't support javascript.
loading
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.
Fagerholm, Rainer; Schmidt, Marjanka K; Khan, Sofia; Rafiq, Sajjad; Tapper, William; Aittomäki, Kristiina; Greco, Dario; Heikkinen, Tuomas; Muranen, Taru A; Fasching, Peter A; Janni, Wolfgang; Weinshilboum, Richard; Loehberg, Christian R; Hopper, John L; Southey, Melissa C; Keeman, Renske; Lindblom, Annika; Margolin, Sara; Mannermaa, Arto; Kataja, Vesa; Chenevix-Trench, Georgia; Lambrechts, Diether; Wildiers, Hans; Chang-Claude, Jenny; Seibold, Petra; Couch, Fergus J; Olson, Janet E; Andrulis, Irene L; Knight, Julia A; García-Closas, Montserrat; Figueroa, Jonine; Hooning, Maartje J; Jager, Agnes; Shah, Mitul; Perkins, Barbara J; Luben, Robert; Hamann, Ute; Kabisch, Maria; Czene, Kamila; Hall, Per; Easton, Douglas F; Pharoah, Paul D P; Liu, Jianjun; Eccles, Diana; Blomqvist, Carl; Nevanlinna, Heli.
Afiliación
  • Fagerholm R; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Khan S; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Rafiq S; Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
  • Tapper W; Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
  • Aittomäki K; Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Greco D; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Heikkinen T; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Janni W; Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA.
  • Weinshilboum R; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Loehberg CR; Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Mayo Medical School-Mayo Foundation, Rochester, MN, USA.
  • Hopper JL; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Southey MC; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Keeman R; Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Lindblom A; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Margolin S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Mannermaa A; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Kataja V; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
  • Chenevix-Trench G; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.
  • Lambrechts D; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
  • Wildiers H; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Seibold P; Vesalius Research Center (VRC), VIB, Leuven, Belgium.
  • Couch FJ; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
  • Olson JE; Multidisciplinary Breast Center, Medical Oncology, University Hospital Leuven, Leuven, Belgium.
  • Andrulis IL; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Knight JA; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • García-Closas M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Figueroa J; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Hooning MJ; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Jager A; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Shah M; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Perkins BJ; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Luben R; Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK.
  • Hamann U; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
  • Kabisch M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Czene K; Department of Medical Oncology, Erasmus MC Cancer Institute, 3008 AE Rotterdam, The Netherlands.
  • Hall P; Department of Medical Oncology, Erasmus MC Cancer Institute, 3008 AE Rotterdam, The Netherlands.
  • Easton DF; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, UK.
  • Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, UK.
  • Liu J; Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Eccles D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Blomqvist C; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Nevanlinna H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Oncotarget ; 6(10): 7390-407, 2015 Apr 10.
Article en En | MEDLINE | ID: mdl-25823661
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article País de afiliación: Finlandia